Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ion Codreanu

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Acta Dermatovenerologica Croatica : ADC|January 13, 2025
Erlotinib-induced Perioral Lesions Resembling SclerodermaConstantin A Dasanu, Juliana Alvarez-Argote, Rossel G Dasanu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 24, 2018
Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?Constantin A Dasanu, Michael Del Rosario, Ion Codreanu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 15, 2019
Severe left atrial enlargement due to carfilzomib use in multiple myelomaConstantin A Dasanu, Steven C Plaxe, Iliana M Popescu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 27, 2018
Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents?Constantin A Dasanu, Yazeed Samara, Ion Codreanu, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|August 19, 2010
Longitudinally and circumferentially directed movements of the left ventricle studied by cardiovascular magnetic resonance phase contrast velocity mappingIon Codreanu, Matthew D Robson, Stephen J Golding, et al.
Expert Opinion on Pharmacotherapy|August 7, 2024
Evaluation of infectious morbidity due to BTK inhibitors in indolent B-cell lymphomas: latest research findings and systematic analysisConstantin A Dasanu, Samar K Mann, Melvin Baidya, et al.
Dermatology Online Journal|March 14, 2019
Merkel cell carcinoma: long-term follow-up of a single institution series and clinical outcomes by immunological statusConstantin A Dasanu, Michael Del Rosario, Ion Codreanu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 13, 2021
Advanced uterine papillary serous cancer: Could there be a role for newer targeted therapeutic approaches or immune checkpoint inhibitors?Constantin A Dasanu, Jaren Lerner, Miguel Michel Ocampo, et al.
Vascular Health and Risk Management|July 7, 2011
Chasing the reflected wave back into the heart: a new hypothesis while the jury is still outIon Codreanu, Matthew D Robson, Oliver J Rider, et al.
Molecular Imaging and Biology|August 1, 2014
Application of partial volume effect correction and 4D PET in the quantification of FDG avid lung lesionsAli Salavati, Samuel Borofsky, Teo K Boon-Keng, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Acta Dermatovenerologica Croatica : ADC|January 13, 2025
Erlotinib-induced Perioral Lesions Resembling SclerodermaConstantin A Dasanu, Juliana Alvarez-Argote, Rossel G Dasanu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 24, 2018
Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?Constantin A Dasanu, Michael Del Rosario, Ion Codreanu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 15, 2019
Severe left atrial enlargement due to carfilzomib use in multiple myelomaConstantin A Dasanu, Steven C Plaxe, Iliana M Popescu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 27, 2018
Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents?Constantin A Dasanu, Yazeed Samara, Ion Codreanu, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|August 19, 2010
Longitudinally and circumferentially directed movements of the left ventricle studied by cardiovascular magnetic resonance phase contrast velocity mappingIon Codreanu, Matthew D Robson, Stephen J Golding, et al.
Expert Opinion on Pharmacotherapy|August 7, 2024
Evaluation of infectious morbidity due to BTK inhibitors in indolent B-cell lymphomas: latest research findings and systematic analysisConstantin A Dasanu, Samar K Mann, Melvin Baidya, et al.
Dermatology Online Journal|March 14, 2019
Merkel cell carcinoma: long-term follow-up of a single institution series and clinical outcomes by immunological statusConstantin A Dasanu, Michael Del Rosario, Ion Codreanu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 13, 2021
Advanced uterine papillary serous cancer: Could there be a role for newer targeted therapeutic approaches or immune checkpoint inhibitors?Constantin A Dasanu, Jaren Lerner, Miguel Michel Ocampo, et al.
Vascular Health and Risk Management|July 7, 2011
Chasing the reflected wave back into the heart: a new hypothesis while the jury is still outIon Codreanu, Matthew D Robson, Oliver J Rider, et al.
Molecular Imaging and Biology|August 1, 2014
Application of partial volume effect correction and 4D PET in the quantification of FDG avid lung lesionsAli Salavati, Samuel Borofsky, Teo K Boon-Keng, et al.
Pageof 7